Research & Development
17 June 2024 - Immuno-oncology company AstraZeneca (LSE: AZN) (STO: AZN) (Nasdaq: AZN) announced on Monday that Imfinzi (durvalumab), combined with carboplatin and paclitaxel followed by Imfinzi monot...
17 June 2024 - Moleculin Biotech, Inc., (Nasdaq: MBRX), a Texas-based clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumours and viruses, repor...
14 June 2024 - In-vitro diagnostics and laboratory services company Renalytix plc (NASDAQ:RNLX) (LSE:RENX) announced on Friday Medicare's final coverage determination for its kidney disease test,...
14 June 2024 - Xeltis, a Netherlands-based developer of transformative implants, announced on Thursday that it has gained approval from the US Food and Drug Administration (FDA) for an Investigational...
12 June 2024 - CSL Seqirus, a business of Australian biotech firm CSL (ASX: CSL), announced on Tuesday that it has been selected by the Health Emergency Preparedness and Response Authority (HERA), par...
11 June 2024 - Commercial-stage biopharmaceutical company InnoCare Pharma (HKEX:09969) (SSE:688428) announced on Tuesday that it has received US Food and Drug Administration (FDA) clearance for a clin...